Anthony Kim
2020 - TapImmune
In 2020, Anthony Kim earned a total compensation of $829.3K as Chief Financial Officer at TapImmune.
Compensation breakdown
| Non-Equity Incentive Plan | $158,000 |
|---|---|
| Option Awards | $278,400 |
| Salary | $392,906 |
| Total | $829,306 |
Kim received $392.9K in salary, accounting for 47% of the total pay in 2020.
Kim also received $158K in non-equity incentive plan and $278.4K in option awards.
Rankings
In 2020, Anthony Kim's compensation ranked 9,358th out of 13,090 executives tracked by ExecPay. In other words, Kim earned more than 28.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,358 out of 13,090 | 29th |
Division Manufacturing | 3,995 out of 5,624 | 29th |
Major group Chemicals And Allied Products | 1,625 out of 2,257 | 28th |
Industry group Drugs | 1,422 out of 1,957 | 27th |
Industry Pharmaceutical Preparations | 1,044 out of 1,462 | 29th |
Source: SEC filing on April 15, 2022.
Kim's colleagues
We found two more compensation records of executives who worked with Anthony Kim at TapImmune in 2020.